BR112018076089A2 - processo de preparação de anticorpos anti-amh e usos dos mesmos - Google Patents

processo de preparação de anticorpos anti-amh e usos dos mesmos

Info

Publication number
BR112018076089A2
BR112018076089A2 BR112018076089-7A BR112018076089A BR112018076089A2 BR 112018076089 A2 BR112018076089 A2 BR 112018076089A2 BR 112018076089 A BR112018076089 A BR 112018076089A BR 112018076089 A2 BR112018076089 A2 BR 112018076089A2
Authority
BR
Brazil
Prior art keywords
preparation process
antibody preparation
amh
amh antibody
antibodies
Prior art date
Application number
BR112018076089-7A
Other languages
English (en)
Inventor
Ataman-Onal Yasemin
Cheucle Sylvie
Combe Maxime
Daniel Soizic
Ottone Sophie
Original Assignee
Biomerieux
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux filed Critical Biomerieux
Publication of BR112018076089A2 publication Critical patent/BR112018076089A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/367—Infertility, e.g. sperm disorder, ovulatory dysfunction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

a presente invenção refere-se a um processo de preparação de anticorpos anti-amh de mamífero. a presente invenção também se refere aos anticorpos e fragmentos de anticorpo e ao uso dos mesmos para avaliar o amh, em particular em fertilidade.
BR112018076089-7A 2016-06-17 2017-06-16 processo de preparação de anticorpos anti-amh e usos dos mesmos BR112018076089A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16175041.9 2016-06-17
EP16175041.9A EP3257867A1 (fr) 2016-06-17 2016-06-17 Procédé de préparation d'anticorps anti-amh et leurs utilisations
PCT/EP2017/064759 WO2017216334A1 (fr) 2016-06-17 2017-06-16 Procédé de préparation d'anticorps anti-amh et leurs utilisations

Publications (1)

Publication Number Publication Date
BR112018076089A2 true BR112018076089A2 (pt) 2019-03-26

Family

ID=56148195

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018076089-7A BR112018076089A2 (pt) 2016-06-17 2017-06-16 processo de preparação de anticorpos anti-amh e usos dos mesmos

Country Status (8)

Country Link
US (1) US11225518B2 (pt)
EP (2) EP3257867A1 (pt)
JP (1) JP7057759B2 (pt)
CN (1) CN109563163A (pt)
AU (1) AU2017285276B2 (pt)
BR (1) BR112018076089A2 (pt)
RU (1) RU2764198C2 (pt)
WO (1) WO2017216334A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111196851B (zh) * 2018-11-20 2021-11-16 厦门万泰凯瑞生物技术有限公司 针对人抗缪勒管激素的特异性抗体及其应用
CN110128535A (zh) * 2019-03-27 2019-08-16 浙江工业大学 一种amh单克隆抗体及其制备与应用
CN114945588A (zh) * 2019-10-30 2022-08-26 莫纳什大学 抗缪勒氏管激素多肽
CN111004326A (zh) * 2019-12-27 2020-04-14 苏州博方生物技术有限公司 一种抗amh单克隆抗体及其制备方法和应用
CN111273042B (zh) * 2020-01-21 2023-09-01 迈克生物股份有限公司 抗缪勒氏管激素检测试剂盒
CN111217907B (zh) * 2020-01-21 2021-03-30 四川大学 抗amh单克隆抗体及其应用
CN112251444B (zh) * 2020-10-21 2023-05-16 恺佧生物科技(上海)有限公司 一种改造的amh基因序列及利用其制备amh的方法
CN115094088A (zh) * 2022-04-19 2022-09-23 华南农业大学 一种pSFV-flagX-CMV复制子质粒、制备方法和鸡尾酒混合疫苗
CN114891104B (zh) * 2022-06-09 2022-12-20 优睿赛思(武汉)生物科技有限公司 识别amh的单克隆抗体及其应用
CN116375864B (zh) * 2023-05-16 2023-08-08 成都大熊猫繁育研究基地 一种抗大熊猫amh单克隆抗体、杂交瘤细胞株及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196265A (en) * 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
GB9104498D0 (en) 1991-03-04 1991-04-17 Ks Biomedix Ltd Antibody
JP4852712B2 (ja) * 2005-05-24 2012-01-11 ベックマン コールター， インコーポレイテッド 抗ミュラー管ホルモンについての免疫アッセイおよび抗体
US7429487B2 (en) 2005-07-05 2008-09-30 Epitomics, Inc. Fusion partner for production of monoclonal rabbit antibodies
WO2008153433A1 (en) * 2007-06-09 2008-12-18 State Research Institute Of Highly Pure Biopreparations (Srihpb) Monoclonal antibodies for detection of mullerian inhibiting substance and uses thereof
AU2013342190B2 (en) 2012-11-09 2018-11-08 Ansh Labs Llc Antibody compositions and immunoassay methods to detect isoforms of Anti-Mullerian Hormone
EP3011337A4 (en) * 2013-06-21 2016-12-21 Otago Innovation Ltd ASSAY FOR THE ANTI-MÜLLER-HORMON
RU2535096C1 (ru) * 2013-08-22 2014-12-10 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский институт акушерства и педиатрии" Министерства здравоохранения Российской Федерации Способ диагностики нарушений менструальной функции на фоне синдрома поликистозных яичников у девочек-подростков
CN103728459A (zh) * 2013-12-25 2014-04-16 李志荣 一种基于量子点的双夹心免疫荧光定量检测人抗苗勒氏管激素amh的试剂盒制备方法及其应用

Also Published As

Publication number Publication date
EP3257867A1 (fr) 2017-12-20
JP2019528676A (ja) 2019-10-17
EP3472204A1 (fr) 2019-04-24
US11225518B2 (en) 2022-01-18
CN109563163A (zh) 2019-04-02
RU2019101062A3 (pt) 2020-10-14
WO2017216334A1 (fr) 2017-12-21
US20190211096A1 (en) 2019-07-11
RU2019101062A (ru) 2020-07-17
AU2017285276B2 (en) 2024-07-18
JP7057759B2 (ja) 2022-04-20
AU2017285276A1 (en) 2019-01-31
RU2764198C2 (ru) 2022-01-14

Similar Documents

Publication Publication Date Title
BR112018076089A2 (pt) processo de preparação de anticorpos anti-amh e usos dos mesmos
CL2020003409A1 (es) Moléculas de unión específicas para cd73 y métodos de fabricación de las mismas (divisional de la solicitud no. 201701154)
CU20180024A7 (es) Moléculas de unión a linfopoyetina estromal tímica (tslp), composiciones farmacéuticas que las contienen y método de producción de las mismas
ECSP20024555A (es) Anticuerpos especificos para cd47 y pd-l1
CO2018010458A2 (es) Composiciones y anticuerpos anti-tim-3
BR112016025291A2 (pt) conjugados de anticorpo anti-ptk7-fármaco
BR112018005164A2 (pt) anticorpos, ácido nucleico, célula hospedeira, método para produzir um anticorpo, formulação farmacêutica, uso do anticorpo e método de tratamento de um indivíduo que tem câncer
BR112019004998A2 (pt) anticorpos anti-pd-1(cd279)
BR112018006360A2 (pt) anticorpos agonísticos que se ligam especificamente ao cd40 humano e métodos de uso
CO2018001624A2 (es) Conjugados anticuerpo anti-dll3-fármaco y métodos de uso
BR112018074468A2 (pt) anticorpos anti-cd40 e suas utilizações
BR112018071276A2 (pt) anticorpos anti-il-33, composições, métodos e usos dos mesmos
UY36889A (es) Moléculas de unión a linfopoyetina estromal timica (tslp) y métodos de uso de las moléculas
BR112017011326A2 (pt) anticorpo, ácido nucleico, vetor, célula hospedeira, método para produzir o anticorpo, imunoconjugado, composição farmacêutica, usos do anticorpo, métodos para tratar ou retardar a progressão de distúrbio proliferativo celular e para intensificar a função imune
BR112016020112A2 (pt) anticorpos multiespecíficos, método para a preparação de um anticorpo multiespecífico, ácido nucleico, vetor de expressão e composição farmacêutica
CO2018000410A2 (es) Moléculas de anticuerpo que se unen a cd79
BR112016005816A2 (pt) Combinação de anticorpos anti-lag-3 e anticorpos anti-pd-1 para tratar tumores
MX2020003562A (es) Anticuerpo multiespecifico.
BR112015025306A2 (pt) anticorpo biespecífico, anticorpos, composição farmacêutica, uso do anticorpo biespecífico, sequência de ácido nucleico, vetor de expressão, célula hospedeira procariótica ou eucariótica e método de produção de um anticorpo
BR112018012344A2 (pt) anticorpos que se ligam especificamente a hla-dr e seus usos
BR112016014731A2 (pt) Anticorpos anti-baff
BR112015030356A2 (pt) métodos de tratamento de uma taupatia
BR112017021376A2 (pt) Estireno [bis(tri-hidrocarbilsilil)aminossilil]- funcionalizado e um método para sua preparação
BR112018010605A2 (pt) nanoemulsões de bebidas produzidas por processamento de alto cisalhamento
BR112017023131A2 (pt) anticorpos anti- fcrn

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]